main
proteinas
sarsassoci
coronaviru
sarscov
play
import
role
viral
transcript
replic
attract
target
antisar
drug
develop
import
thing
understand
bind
mechan
possibl
ligand
studi
investig
possibl
noncanon
interact
potenti
inhibitor
bind
pocket
main
proteinas
sarscov
base
recent
determin
crystal
structur
find
provid
wide
clue
search
antisar
drug
interestingli
found
similar
structur
pattern
exist
sarscov
main
proteinas
polioviru
proteinas
rhinoviru
explor
bind
mechan
main
proteinas
sarsassoci
coronaviru
implic
antisar
drug
design
sinc
novemb
highli
contagi
pneumonia
sever
acut
respiratori
syndrom
sar
spread
rapidli
asia
north
america
europ
new
sar
coronaviru
sarscov
identifi
etiolog
agent
diseas
serious
lie
rapid
transmiss
high
fatal
around
howev
origin
sarscov
still
unknown
effect
drug
vaccin
avail
sarscov
replicas
encod
two
overlap
polyprotein
mediat
viral
replic
transcript
special
main
proteinas
proteinas
respons
cleavag
polyprotein
function
import
make
attract
target
drug
develop
fortun
crystal
structur
sarscov
main
proteinas
determin
adopt
serineproteas
fold
homolog
main
proteinas
human
coronaviru
transmiss
gastroenter
viru
goal
studi
find
potenti
inhibitor
locat
ligandbind
site
sarscov
main
proteinas
base
comparison
nonhomolog
tertiari
structur
henc
provid
clue
ration
drug
design
atom
coordin
sarscov
main
proteinas
download
protein
data
bank
id
nci
program
use
identifi
noncanon
interact
vast
http
wwwncbinlmnihgov
structurevastvastsearchhtml
dali
http
wwwebiac
ukdali
program
use
find
similar
structur
pattern
main
proteinas
structur
sarscov
structur
align
done
ce
structur
comparison
perform
lga
constitu
bind
pocket
determin
residu
least
one
heavi
atom
hydrogen
distanc
less
heavi
atom
inhibitor
chou
et
al
visual
structur
gener
keyword
sarscov
main
proteinas
noncanon
interact
inhibitor
bind
proteinexplor
http
wwwproteinexplorerorg
noncanon
interact
sarscov
main
proteinas
structur
shown
figur
two
pair
main
chainsid
chain
interact
donor
trp
acceptor
donor
acceptor
four
pair
side
chainsid
chain
interact
donor
acceptor
donor
acceptor
donor
acceptor
donor
acceptor
residu
mark
figur
among
interact
accept
two
p
bond
sandwich
fashion
one
donat
sidesid
chain
one
donat
mainsid
chian
exist
human
taken
togeth
anoth
p
interact
noncanon
bind
connect
nterminu
cterminu
enzym
togeth
fix
domain
ii
domain
iii
make
domain
ii
iii
flexibl
due
loop
form
interact
right
loop
alreadi
exist
left
fig
stabil
structur
proteas
furthermor
turn
examin
remain
three
pair
interact
seen
figur
noncanon
bind
abl
stabil
protein
structur
around
activ
center
form
cyshi
catalyt
dyad
hand
bind
small
helix
locat
expect
move
loop
locat
loop
locat
expect
move
henc
make
activ
center
open
substrat
bind
fig
result
use
ration
design
mutagenesi
experi
analysi
conserv
interact
function
site
recent
year
noncanon
interact
shown
import
stabil
protein
structur
ligand
recognit
structur
similar
nonhomolog
viru
protein
identifi
vast
dali
method
focu
proteas
rhinoviru
proteas
inhibitor
polioviru
proteinas
proteinas
equin
arter
viru
hepat
c
viru
proteas
inhibitor
fki
hepat
viru
proteas
inhibitor
nfa
dengu
viru
complex
mungbean
bowmanbirk
inhibitor
structurebas
sequenc
align
six
proteas
sarscov
main
proteas
shown
figur
result
demonstr
number
similar
beta
sheet
mark
b
exist
particular
three
similar
structur
pattern
show
conserv
residu
bold
represent
catalyt
import
residu
includ
first
two
highli
conserv
pattern
hisci
hisser
catalyt
dyad
third
pattern
gli
conserv
proteas
except
sarscov
main
proteinas
signific
mutat
sar
unclear
anyway
three
structur
pattern
form
common
activ
center
seven
enzym
seen
superposit
fig
sinc
nonhomolog
viru
proteas
share
activ
center
consid
possibl
appli
inhibitor
enzym
sarscov
main
proteinas
fact
anand
et
al
indic
inhibitor
may
modifi
make
use
sar
therapi
chou
et
al
conduct
dock
studi
deriv
sarscov
main
proteinas
base
theoret
model
studi
possibl
inhibitor
antisar
drug
develop
figur
show
structur
dock
inhibitor
hav
hcv
dengu
viru
sarscov
main
proteinas
residu
make
contact
inhibitor
mark
figur
furthermor
correspond
bind
pocket
shown
tabl
result
reveal
inhibitor
bind
sarscov
main
proteinas
well
thu
result
suggest
link
sarscov
human
rhinoviru
polioviru
arter
viru
hav
hcv
dengu
viru
inhibitor
virus
could
modifi
make
use
sar
therapi
fact
cinatl
et
al
report
human
interferon
medicin
wide
use
hcv
patient
use
treatment
sar
anyway
whether
relationship
sarscov
pathogen
exist
present
result
provid
wide
clue
search
antisar
inhibitor
residu
mark
indic
similar
betasheet
bold
residu
indic
structur
similar
pattern
residu
mark
make
noncanon
interact
residu
mark
make
contact
inhibitor
